At week 36, the following differences were observed for change in 24-hour diastolic blood pressure from baseline relative to placebo therapy: Tirzepatide 5 mg: -2.0 (95% CI, -3.6 to -0.3) mmHg Tirzepatide 10 mg: -2.9 (95% CI, -4.5 to -1.3) mmHg Tirzepatide 15 mg: -0.5 (95% CI, -2.0 to 1.1) mmHg Further analysis suggested these results were consistent across subgroups defined by clinically relevant factors, including age, sex, BMI, and hypertension-related factors
However, individual body composition varies, and some patients may find alternative sites more suitable based on their anatomy and comfort level
For maximum potency and the most established pharmacological data, injectable is the stronger choice
Baseline labs (metabolic panel, HbA1c, lipid panel, thyroid panel, lipase) are reviewed by your prescribing doctor before a prescription is issued
If insurance excludes weight-loss medications (common), compounded tirzepatide at $349-$549/month is usually the cheapest legitimate route, well below brand cash pay